(Q53551598)

15 May 2018

title

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. (English)

1 reference

15 May 2018

Dermatophagoides pteronyssinus

0 references

0 references

1 reference

1 reference

1 reference

Bousquet J

1

1 reference

15 May 2018

Scheinmann P

2

1 reference

15 May 2018

Guinnepain MT

3

1 reference

15 May 2018

Perrin-Fayolle M

4

1 reference

15 May 2018

Sauvaget J

5

1 reference

15 May 2018

Tonnel AB

6

1 reference

15 May 2018

Pauli G

7

1 reference

15 May 2018

Caillaud D

8

1 reference

15 May 2018

Dubost R

9

1 reference

15 May 2018

Leynadier F

10

1 reference

15 May 2018

Vervloet D

11

1 reference

15 May 2018

Herman D

12

1 reference

15 May 2018

Galvain S

13

1 reference

15 May 2018

André C

14

1 reference

15 May 2018

publication date

1 March 1999

1 reference

15 May 2018

published in

Allergy

1 reference

15 May 2018

volume

54

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

page(s)

249-260

1 reference

15 May 2018

Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

Heterogeneity of bronchial asthma. Sub-populations--or different stages of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

21 January 2018

Sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

7 January 2021

Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

7 January 2021

Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

7 January 2021

Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

7 January 2021

A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

7 January 2021

Prediction of mite allergen levels by guanine measurements in house-dust samples

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

7 January 2021

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

7 January 2021

Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.00916.X

7 January 2021

10.1034/J.1398-9995.1999.00916.X

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018